Document is current

Any future updates will be listed below

1364 Bispecific antibodies that block TIM-3 and CD39 induce anti-tumor efficacy and immune response by blocking multiple suppressive mechanisms

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.1364

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark